Drägerwerk AG & Co. KGaA EBITDA margin
What is the EBITDA margin of Drägerwerk AG & Co. KGaA?
The EBITDA margin of Drägerwerk AG & Co. KGaA is 1.23%
What is the definition of EBITDA margin?
EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.
ttm (trailing twelve months)
EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.
EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.
EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.
EBITDA margin of companies in the Health Care sector on XETRA compared to Drägerwerk AG & Co. KGaA
What does Drägerwerk AG & Co. KGaA do?
Drägerwerk AG & Co. KGaA operates as a medical and safety technology company in Europe, the Americas, Africa, Asia, and Australia. The company develops, produces, and markets system solutions, equipment, and services for acute point of care, including emergency care, perioperative care, critical care, and perinatal care. It also develops, produces, and markets products, system solutions, and services for personal protection, gas detection technology, and integrated hazard management to customers in industry and mining sectors, as well as public sectors, such as fire departments, police, and disaster protection. The company's products portfolio includes anesthesia devices and ventilators, thermoregulation equipment, consumables and accessories, supply units, lights, gas management systems, patient monitoring, software applications, and system products. Its product portfolio also comprises stationary and mobile gas detection systems, personal protective equipment, professional diving equipment and systems, and alcohol and drug testing devices. In addition, the company offers various training and services, as well as undertakes projects that include fire training systems. Drägerwerk AG & Co. KGaA was founded in 1889 and is headquartered in Lübeck, Germany.
Companies with ebitda margin similar to Drägerwerk AG & Co. KGaA
- Keppel has EBITDA margin of 1.23%
- Orient Victory Travel has EBITDA margin of 1.23%
- Chunghwa Telecom has EBITDA margin of 1.23%
- Hennes & Mauritz AB has EBITDA margin of 1.23%
- Great Elm Capital Corp has EBITDA margin of 1.23%
- CBAK Technology Inc has EBITDA margin of 1.23%
- Drägerwerk AG & Co. KGaA has EBITDA margin of 1.23%
- Revolution Beauty plc has EBITDA margin of 1.24%
- Owens & Minor has EBITDA margin of 1.24%
- Le Tanneur & Cie Societe anonyme has EBITDA margin of 1.24%
- Central Puerto has EBITDA margin of 1.24%
- Valson Industries has EBITDA margin of 1.25%
- JCT has EBITDA margin of 1.25%